The “6th Annual Maryland Stem Cell Research Symposium” at the Johns Hopkins Medical Campus in Baltimore Maryland on December 3, 2013
The Symposium is the Maryland Stem Cell Research Fund premier event that delivers comprehensive scientific talks, poster presentations, Ethics discussions and networking time, enabling cell therapy basic research and technologies from the lab to pre-clinical and to commercialization.
With a powerful line-up of speakers and many opportunities for you to present your work in concurrent or poster presentations, the Symposium will follow the format and style of previous meetings with an additional networking time and an intimate environment.
The Maryland Stem Cell Research Fund is now accepting abstract submissions for poster and oral presentations for the 6th Annual Maryland Stem Cell Research Symposium. We encourage you to take full advantage of this opportunity to share your research results with our community. Multiple abstract submissions are welcomed.
ABSTRACT SUBMISSION DEADLINE PASSED!
Over 125 abstracts submitted and all of them will be presenting during the Symposium. Several will be selected to give an oral presentation as well. The full list will be available soon.
7:00am-8:00am - Registration and Breakfast
8:00am-8:15am - Opening Remarks Avram Reisner, Commission Chair
8:15am-9:00am - The John L. Kellermann III Memorial Lecture
Rita Perlingeiro, Associate Professor and Lillehei Endowed Scholar Lillehei Heart Institute University of Minnesota - From iPS cells to Skeletal Muscle Precursors: Potential for Gene Correction and Therapeutic Application
9:00am-10:30am - Plenary Session I - 25 min talk 5 min Q&A - Moderator: Dan Gincel
- Gabsang Lee, Johns Hopkins University, School of Medicine - Direct conversion of human fibroblastsÂ into induced neural crest (iNC)
- Elias Zambidis, The Johns Hopkins School of Medicine - Clinical-Grade Human iPSC for Regenerative Medicine
- Yoon-Young Jang, Johns Hopkins Medical Institutions - Applications of iPSC technology for liver diseases and drug toxicity
10:30am-10:45am - Networking break
10:45am-12:00pm - Plenary Session II - 12 min talk 3 min Q&A - Moderator: Ricardo Feldman
- MinJung Kim, University of Maryland Baltimore School of Medicine - MiR-144 and miR-451 regulate human erythroid Differentiation
- Mingyao Ying, Hugo W. Moser Research Institute at Kennedy Krieger - Highly Efficient Induction of Dopaminergic Neurons from Human Pluripotent Stem Cells
- Judi Sgambato, University of Maryland Baltimore - Altered Differentiation Potential In iPSC-Derived Gaucher Disease-Specific Hematopoietic Progenitor Cells
- Ludovic Zimmerlin, Johns Hopkins University School of Medicine - Genetic correction of sickle cell disease human IPSC converted to a murine ESC like state
- Dawei Gong, University of Maryland Baltimore, Derivation of human brown adipocytes through cellular reprogramming
12:00pm-1:30pm - Lunch, Networking & Poster Viewing
1:30pm-3:00pm - Plenary Session III - 25 min talk 5 min Q&A - Moderator: Kathryn Wagner
- Kathryn Wagner, Hugo W. Moser Research Institute at Kennedy Krieger and Johns Hopkins University School of Medicine - A Xenograft model for neuromuscular disease
- Robert Brodsky, Johns Hopkins University School of Medicine - Regenerative medicine to treat genetic and autoimmune diseases
- Linzhao Cheng, Johns Hopkins University - Human iPS cells and genome editing: blood disease modeling and treatment
3:00pm-3:15pm - Networking break
3:15pm-5:00pm - Plenary Session IV - 12 min talk 3 min Q&A - Moderator: Yoon-Young Jang
- Ying Wang, Johns Hopkins University - Scalable Expansion and Red Blood Cell Production of Human iPS Cells Derived From a Sickle Patient Under Chemically-Defined Condition
- Jessica Tilghman, Johns Hopkins School of Medicine - Regulation of Neural and Neoplastic Stem Cells by Kruppel-Like Transcription Factors
- Yu I Shen, Johns Hopkins University - Engineering Functional Vascular Networks Using Hydrogel and Vascular Stem Cells to Augment Diabetic Wound Healing
- Pratik Nagaria, University of Maryland Baltimore, Efficacy of Remodeling the DNA Damage Response in Induced Pluripotent Stem Cells Engineered by Different Methods
- William Rust, Seraxis Inc, Clinical development of an iPS-based cell therapy for diabetes
- Christopher Donnelly, Johns Hopkins University, RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention
- Kevin Francis, National Institute of Child Health and Human Development - Patient-Derived IPS Cells Identify Role For Cholesterol/Wnt Interactions In Balancing Pluripotency and Neural Differentiation
5:00pm-7:00pm - Closing remarks, poster viewing and reception
- 5:00pm-6:00pm - Even number presenting
- 6:00pm-7:00pm - Odd number presenting
Turner Auditorium, Johns Hopkins School of Medicine
720 Rutland Ave. Baltimore, MD 21205
On-line registration is now closed...
Walk-Ins are welcome!